Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
It has demonstrated encouraging results in clinical trials; however, it isn't approved just yet. While the optimism surrounding the drug made Viking's stock a hot buy early last year, things have drastically cooled over the past six months during which it has plummeted more than 50%. As a result, the stock is now down 65% from its 52-week high of $89.10. Is this a good time to buy shares of Viking Therapeutics, or could more of a decline be coming this year? Making a bullish case for Viking Therapeutics stock isn't difficult. VK2735 has helped participants in a phase 2 trial lose around 15% of their body weight -- and that's without a plateau observed, meaning that even higher weight loss is possible. That was over the course of just a 13-week study; over a longer time frame, it may perform even better. However, even at 15%, if those results hold up for the long term, that can make the drug a formidable alternative to other GLP-1 injections. A phase 3 trial is planned later this
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.MarketBeat
- Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $104.00 price target on the stock.MarketBeat
- Why Viking Therapeutics Stock Popped Today [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $75.00 price target on the stock, down previously from $95.00.MarketBeat
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Morgan Stanley from $105.00 to $102.00. They now have an "overweight" rating on the stock.MarketBeat
VKTX
Earnings
- 4/23/25 - Miss
VKTX
Sec Filings
- 4/24/25 - Form 10-Q
- 4/23/25 - Form DEFA14A
- 4/23/25 - Form DEFR14A
- VKTX's page on the SEC website